Published in Healthcare Finance, Tax and Law Weekly, November 2nd, 2005
The case was filed by Novamedix in 1992 and relates to KCI's PlexiPulse line of foot pump products used for the prevention of deep-vein thrombosis.
Under the terms of the settlement, KCI has agreed to pay Novamedix $75 million and to assign or license certain KCI foot pump patent rights to Novamedix. KCI will also retain rights under the patents. The settlement resolves and settles all claims between the parties in the case.
For the last 12-month period ended...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.